Who invested in Faze Medicines?
Faze Medicines's investors include Invus, Eli Lilly, Catalio Capital Management, Casdin Capital and AbbVie.
Who invested in Faze Medicines
Funding summaryUpdated 26 Oct 2026
$81Mraised across 1 round since 2020, from 1 source
- Latest round
- Series A, $81MDec 2020
- Investors
- 5
The rounds
- Dec 2020Series A$81M
Source recordedSEC filing: $30M sold, first sale Dec 2020
Founders and team
From the SEC filings it signed: 2 on the team.
- Cary PfefferExecutive Officer, Directori
- Ed FreedmanExecutive Officer, Directori
On the board, as filediCharles HomcyRobert Tepper
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Faze Medicines
How much has Faze Medicines raised?
Faze Medicines has raised $81M across 1 round since 2020.
When did Faze Medicines last raise?
Faze Medicines's most recent round was a Series A of $81M in Dec 2020.
What was Faze Medicines's biggest round?
Its most recent round, $81M in Dec 2020, is also its largest on record.
Who backed Faze Medicines first?
Faze Medicines's first round on record, in Dec 2020, was backed by Invus, Eli Lilly and Catalio Capital Management and 2 others.
What stage is Faze Medicines at?
Faze Medicines's latest named round is a Series A, in Dec 2020.
Companies like Faze Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.